Advertisement

Virchows Archiv A

, Volume 410, Issue 4, pp 347–354 | Cite as

Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue

  • Sonja C. Henzen-Logmans
  • Hendrik Mullink
  • Frans C. S. Ramaekers
  • Thea Tadema
  • Chris J. L. M. Meijer
Article

Summary

The presence of intermediate filament proteins of the cytokeratin and vimentin type was evaluated in normal and pathologically changed thyroid tissue specimens. Using the indirect immunoperoxidase technique with 4 different cytokeratin monoclonal antibodies: RCK114 (broad spectred), K2080 (broad spectred), RGE53 (directed against component 18, present in simple epithelium) and RKSE60 (directed against component 10, associated with keratinization). Co-expression of cytokeratin and vimentin was evaluated with a double immunoenzyme staining technique.

The results indicate that normal and transformed cells express cytokeratins of the non-epidermal type. Cytokeratins of the epidermal type are sometimes present in carcinomas. They do not differentiate in tumour type (i.e. papillary, follicular, anaplastic or medullary carcinoma).

The co-expression of cytokeratins and vimentin is not restricted to carcinomas: in a small percentage of cases it is also present in normal epithelial cells of the thyroid gland. Moreover, the distribution pattern of cytokeratins and vimentin within the cell is changed in malignant transformed epithelial cells of the gland and seems to be inversely related to the degree of differentiation of these cells. The implications of our findings for the possible use of cytokeratins and vimentin in diagnostic pathology are discussed.

Key words

Thyroid gland Thyroid cancer Intermediate filaments Immunohistochemistry 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bennett CS, Fellini SA, Croop JL, Otto JS, Bryan J, Holtzer H (1982) Differences among the 100 A filament subunits from different cell types. Proc Nature Acad Sci USA 75:4364–4368Google Scholar
  2. Bodemer ChW (1970) Modern embryology. Holt, Rinehart & Winston Inc Great Britain 262Google Scholar
  3. Erlandson RA (1984) Diagnostic immunohistochemistry of human tumours. Am J Surg Pathol 8:615–624Google Scholar
  4. Franke WW, Schmid E, Osborn M, Weber K (1978) Different intermediate-sized filaments distinguished by immunofluorescence microscopy. Proc Acad Sci USA 75:5034–5038Google Scholar
  5. Franke WW, Schmid E, Winter S, Osborn M, Weber K (1979) Widespread occurrence of intermediate-sized filaments of the vimentin type in cultured cells from diverse vertebrates. Exp Cell Res 123:25–46Google Scholar
  6. Franke WW, Schmid E, Schiller DL, Winter J, Jarash ED, Moll R, Denn H, Jackson BW (1982) Differentiation related patterns of expression of proteins of intermediate-sized filaments in tissues and cultured cells. Cold Spring Harbor Symp Quant Biol 46:431–453Google Scholar
  7. Gabbiani G, Kapanci Y, Barazzone Ph, Franke WW (1981) Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist. Am J Pathol 104:206–216Google Scholar
  8. Gabbiani G, Kocher O (1983) Cytocontractile and cytoskeletal elements in pathologic processes. Archiv Pathol Lab Med 107:622–625Google Scholar
  9. Hedinger Chr, Sobin CH (1974) Histological typing of thyroid tumours. World Health Organization, GenevaGoogle Scholar
  10. Herman CJ, Moesker O, Kant A, Huysman A, Vooys P, Ramaekers FCS (1983) Is renal cell (Grawitz) tumor a carcinosarcoma? Virchows Arch [Cell pathol] 44:73–83Google Scholar
  11. Jasani B, Edwards RE, Thomas ND, Gibbs AR (1985) The use of vimentin antibodies in the diagnosis of malignant mesothelioma. Virchows Arch [Pathol Anat] 406:441–448Google Scholar
  12. Lazarides E (1980) Intermediate filaments as mechanical integrators of cellular space. Nature 283:249–256Google Scholar
  13. Logmans SC, Jöbsis AC (1984) Thyroid associated antigens in routinely embedded carcinomas. Possibilities and limitations studied in 116 cases. Cancer 54:274–279Google Scholar
  14. Miettinen M, Lehto V, Virtanen I (1984a) Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors. Ultrastr Pathol 7:83–107Google Scholar
  15. Miettinen M, Fransilla K, Lehto V, Paasivo R, Virtanen I (1984b) Expression of intermediate filament proteins in thyroid gland and thyroid tumors: Lab Invest 50:262–269Google Scholar
  16. Moll R, Franke WW, Schiller DL (1982) The catalogue of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell Vol 31:11–24Google Scholar
  17. Moll R, Moll F, Franke WW (1984) Differences of expression of cytokeratin polypeptides in various epithelial skin tumours. Arch Dermatol Res 276:349–363Google Scholar
  18. Mullink H, Boorsma DM, Henzen-Logmans SC, Meijer CJLM (1986) Double immunoenzyme staining techniques with special reference to monoclonal antibodies. In: Application of monoclonal antibodies in tumorpathology. Eds. Ruiter DJ, Fleuren GJ, Warnaar S, Martinus Nijhoff Publishers, The Hague, New York (in press)Google Scholar
  19. Muyen van G, Ruiter DJ, Ponec M (1984) Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors. Am J Pathol 114:9–17Google Scholar
  20. Osborn M, Weber K (1983) Biology of disease. Tumor diagnosis by intermediate filament typing a novel tool for surgical pathology. Lab Invest 48:372–394Google Scholar
  21. Ramaekers FCS, Puts JJG, Moesker O, Kant A, Jap P, Vooijs GP (1983a) Demonstration of keratin in human adenocarcinomas. AM J Pathol 111:213–223Google Scholar
  22. Ramaekers FCS, Puts JJG, Moesker G, Kant A, Huysmans A, Haag D, Jap P, Herman CJ, Vooijs GP (1983b) Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview. Histochem J 15:691–713Google Scholar
  23. Ramaekers FCS, Haag D, Kant A, Moesker O, Jap PHK, Vooys GP (1983c) Co-expression of keratin and vimentin type intermediate filaments in human metastatic carcinoma cells. Cell Biol 80:2618–2622Google Scholar
  24. Ramaekers FCS, Haag D, Kant A, Moesker O, Jap P, Vooys GP (1984a) Application of antibodies to intermediate filament proteins in cytopathology. J Submicro Cytol 16(1):189–191Google Scholar
  25. Ramaekers FCS, Haag D, Jap P, Vooys GP (1984b) Immunochemical demonstration of keratin and vimentin in cytologic aspirates. Acta Cytol 28:385–392Google Scholar
  26. Rungger-Brändle E, Gabbiani G (1983) The role of cytoskeletal and cytocontractile elements in pathologic processes. Am J Pathol 110/3; 361–381Google Scholar
  27. Valk van der P, Jansen I, Daha MR, Meijer CJLM (1983) Characterization of B-cell NHL. A study using a panel of monoclonal and heterologous antibodies. Virchows Arch [Pathol Anat] 401:289–305Google Scholar
  28. Virtanen I, lehto V-P, Lehtonen E, Vartio T, Stenman S, Kurki P, Wagner O, Small JV, Dahl D, Badly RA (1981) Expression of intermediate filaments in cultured cells. J Cell Sci 50:45–63Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • Sonja C. Henzen-Logmans
    • 1
  • Hendrik Mullink
    • 1
  • Frans C. S. Ramaekers
    • 2
  • Thea Tadema
    • 1
  • Chris J. L. M. Meijer
    • 1
  1. 1.Department of PathologyFree University HospitalAmsterdamThe Netherlands
  2. 2.Department of PathologyUniversity of NijmegenNijmegenThe Netherlands

Personalised recommendations